Supriya Lifescience Limited (NSE:SUPRIYA)
India · Delayed Price · Currency is INR 683.85
+8.05 (1.19%)
May 13, 2026, 3:29 PM IST
Supriya Lifescience Market Cap
Supriya Lifescience has a market cap or net worth of 55.04 billion as of May 13, 2026. Its market cap has decreased by -6.01% in one year.
Market Cap
55.04B
Enterprise Value
54.06B
Revenue
7.35B
Ranking
n/a
PE Ratio
29.68
Stock Price
683.85
Market Cap Chart
Since December 28, 2021, Supriya Lifescience's market cap has increased from 31.46B to 55.04B, an increase of 74.96%. That is a compound annual growth rate of 13.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 54.39B | -10.07% |
| Dec 31, 2025 | 60.48B | 1.58% |
| Dec 31, 2024 | 59.54B | 135.04% |
| Dec 29, 2023 | 25.33B | 33.91% |
| Dec 30, 2022 | 18.92B | -51.41% |
| Dec 31, 2021 | 38.93B | 23.76% |
| Dec 28, 2021 | 31.46B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocon | 615.63B |
| Anthem Biosciences | 440.67B |
| OneSource Specialty Pharma | 210.39B |
| Concord Biotech | 122.81B |
| Blue Jet Healthcare | 85.08B |
| Zota Health Care | 43.50B |
| Dishman Carbogen Amcis | 29.36B |
| Panacea Biotec | 23.81B |